Cargando…
Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms
Autores principales: | Kreuter, Michael, Maher, Toby M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193842/ https://www.ncbi.nlm.nih.gov/pubmed/31978310 http://dx.doi.org/10.1164/rccm.202001-0057ED |
Ejemplares similares
-
Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021) -
Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis?
por: Maher, Toby M.
Publicado: (2021) -
Pulmonary fibrosis secondary to COVID-19: a call to arms?
por: Spagnolo, Paolo, et al.
Publicado: (2020) -
Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
por: Molyneaux, Philip L., et al.
Publicado: (2017) -
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
por: Kreuter, Michael, et al.
Publicado: (2015)